Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Clin Nucl Med ; 46(1): e47-e48, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33156046

RESUMEN

Seminal vesicles are paired secretory glands located posterior to the bladder in men that produce seminal fluid to maintain sperm. Seminal vesicle reflux into the prostatic ducts may be associated with prostatitis in older patients or may represent a very rare complication of transurethral prostate resection in patients with prostatic cancer. This condition is frequently accidentally diagnosed on excretory urography and/or retrograde urethrogram. Clinical presentation includes pain, fever, recurrent epididymitis-prostatitis, and post void dribbling.


Asunto(s)
Colina/análogos & derivados , Tomografía Computarizada por Tomografía de Emisión de Positrones , Neoplasias de la Próstata/diagnóstico por imagen , Neoplasias de la Próstata/cirugía , Vesículas Seminales/fisiopatología , Resección Transuretral de la Próstata/efectos adversos , Anciano , Diagnóstico Diferencial , Humanos , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Neoplasias de la Próstata/patología , Prostatitis/etiología , Prostatitis/fisiopatología
2.
Mol Nutr Food Res ; 64(16): e2000326, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32618118

RESUMEN

SCOPE: Previous studies have identified potent anticancer activities of polyphenols in preventing prostate cancer. The aim of the current study is to evaluate the chemopreventive potential of grape powder (GP) supplemented diets in genetically predisposed and obesity-provoked prostate cancer. METHODS AND RESULTS: Prostate-specific Pten heterozygous (Pten+/f ) transgenic mice are fed low- and high-fat diet (LFD and HFD, respectively) supplemented with 10% GP for 33 weeks, ad libitum. Prostate tissues are characterized using immunohistochemistry and western blots, and sera are analyzed by ELISA and qRT-PCR. Pten+/f mice fed LFD and HFD supplemented with 10% GP show favorable histopathology, significant reduction of the proliferative rate of prostate epithelial cells (Ki67), and rescue of PTEN expression. The most potent protective effect of GP supplementation is detected against HFD-induced increase in inflammation (IL-1ß; TGF-ß1), activation of cell survival pathways (Akt, AR), and angiogenesis (CD31) in Pten+/f mice. Moreover, GP supplementation reduces circulating levels of oncogenic microRNAs (miR-34a; miR-22) in Pten+/f mice. There are no significant changes in body weight and food intake in GP supplemented diet groups. CONCLUSIONS: GP diet supplementation can be a beneficial chemopreventive strategy for obesity-related inflammation and prostate cancer progression. Monitoring serum miRNAs can facilitate the non-invasive evaluation of chemoprevention efficacy.


Asunto(s)
Anticarcinógenos/farmacología , Neoplasia Intraepitelial Prostática/prevención & control , Neoplasias de la Próstata/prevención & control , Vitis/química , Animales , Línea Celular Tumoral , Dieta Alta en Grasa/efectos adversos , Suplementos Dietéticos , Femenino , Haploinsuficiencia/genética , Humanos , Masculino , Ratones Endogámicos C57BL , Ratones Transgénicos , MicroARNs/metabolismo , Fosfohidrolasa PTEN/genética , Polvos , Neoplasia Intraepitelial Prostática/etiología , Neoplasia Intraepitelial Prostática/patología , Neoplasias de la Próstata/etiología , Neoplasias de la Próstata/patología , Prostatitis/etiología , Prostatitis/prevención & control , Aumento de Peso/efectos de los fármacos , Aumento de Peso/genética
3.
World J Urol ; 38(11): 2771-2779, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-32060633

RESUMEN

PURPOSE: To review the role of a persistent prostatic inflammatory status (PIS) in the development and progression of benign prostatic hyperplasia (BPH) associated with lower urinary tract symptoms (LUTS) and which medical therapies approved for LUTS/BPH may reduce persistent PIS. METHODS: Literature search in PubMed up to July 2019. RESULTS: The cause of histologically defined persistent PIS or chronic prostatic inflammation is multifactorial. It is evident in many men with LUTS/BPH, particularly in older men and in men with a large prostate volume or more severe (storage) LUTS. Additionally, persistent PIS is associated with an increased risk of acute urinary retention and symptom worsening. Of medical therapies approved for LUTS/BPH, the current evidence for a reduction of persistent PIS is greatest for the hexanic extract of Serenoa repens (HESr). This treatment relieves LUTS to the same extent as α1-adrenoceptor antagonists and short-term 5α-reductase inhibitors. Limited evidence is available on the effect of other mainstream LUTS/BPH treatments on persistent PIS. CONCLUSIONS: Persistent PIS plays a central role in both the development and progression of LUTS/BPH. In men with LUTS/BPH who have a high chance of harbouring persistent PIS, HESr will not only improve LUTS, but also reduce (underlying) inflammation. Well-designed clinical studies, with a good level of evidence, are required to better evaluate the impact of BPH/LUTS medical therapies on persistent PIS.


Asunto(s)
Síntomas del Sistema Urinario Inferior/tratamiento farmacológico , Síntomas del Sistema Urinario Inferior/etiología , Hiperplasia Prostática/complicaciones , Hiperplasia Prostática/tratamiento farmacológico , Prostatitis/tratamiento farmacológico , Prostatitis/etiología , Humanos , Masculino , Fitoterapia
4.
Int. braz. j. urol ; 46(1): 60-66, Jan.-Feb. 2020. tab
Artículo en Inglés | LILACS | ID: biblio-1056357

RESUMEN

ABSTRACT Objectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. Materials and Methods: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofl oxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofl oxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. Results: Mean age was 62.38±7.30 (47-75), and the mean prostate volume was 43.17±15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the first biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). Conclusions: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet.


Asunto(s)
Humanos , Masculino , Anciano , Ornidazol/administración & dosificación , Prostatitis/etiología , Biopsia con Aguja/efectos adversos , Ciprofloxacina/administración & dosificación , Profilaxis Antibiótica/métodos , Enema/métodos , Antibacterianos/administración & dosificación , Próstata/patología , Prostatitis/prevención & control , Factores de Tiempo , Biopsia con Aguja/métodos , Reproducibilidad de los Resultados , Estudios Retrospectivos , Factores de Riesgo , Resultado del Tratamiento , Ultrasonografía Intervencional , Combinación de Medicamentos , Persona de Mediana Edad
5.
Int Braz J Urol ; 46(1): 60-66, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31851459

RESUMEN

OBJECTIVES: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. MATERIALS AND METHODS: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofloxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofloxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. RESULTS: Mean age was 62.38 ± 7.30 (47-75), and the mean prostate volume was 43.17 ± 15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the fi rst biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). CONCLUSIONS: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet.


Asunto(s)
Antibacterianos/administración & dosificación , Profilaxis Antibiótica/métodos , Biopsia con Aguja/efectos adversos , Ciprofloxacina/administración & dosificación , Enema/métodos , Ornidazol/administración & dosificación , Prostatitis/etiología , Anciano , Biopsia con Aguja/métodos , Combinación de Medicamentos , Humanos , Masculino , Persona de Mediana Edad , Próstata/patología , Prostatitis/prevención & control , Reproducibilidad de los Resultados , Estudios Retrospectivos , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento , Ultrasonografía Intervencional
6.
Artículo en Inglés | MEDLINE | ID: mdl-31632736

RESUMEN

Introduction: Spinal cord injury (SCI), specifically suprasacral SCI, results in high intravesical pressures, elevated post-void residual and urinary incontinence which are all risk factors for urinary tract infections (UTIs). The management of UTIs usually is conservative medical antibiotic treatment. However, recurrent UTIs in the SCI patient population warrant further investigation. The method of urinary drainage (intermittent or indwelling urinary catheters, urinary diversion) and untreated complications of NLUTD (vesicoureteral reflux, stone formation, chronic incomplete emptying of the bladder) are risk factors for recurrent UTIs (rUTIs). Removal of these UTI risk factors and improving urinary drainage are goals of urologic management; however, when conservative interventions do not succeed, surgery may be a viable solution in select cases of rUTIs. Case presentation: We present a case of complicated persisting rUTIs and associated urethral discharge in a middle-aged SCI male who manages his bladder with intermittent catheterization (IC). We detail the evaluation and management approach that leads to an eventual transurethral prostatectomy (TURP) as a final solution for his rUTIs. Fortunately, the surgical intervention was successful, and the patient is free of UTIs after 4 years of follow-up. Discussion: In SCI male patients with rUTIs and suspected chronic prostatitis, TURP may be a valuable treatment option once all predisposing factors have been remediated.


Asunto(s)
Prostatitis/etiología , Prostatitis/cirugía , Traumatismos de la Médula Espinal/complicaciones , Resección Transuretral de la Próstata/métodos , Enfermedad Crónica , Humanos , Masculino , Persona de Mediana Edad
7.
Int J Mol Sci ; 20(19)2019 Sep 26.
Artículo en Inglés | MEDLINE | ID: mdl-31561455

RESUMEN

The effect of low energy shock wave (LESW) therapy on the changes of inflammatory molecules and pain reaction was studied in a capsaicin (10 mM, 0.1 cc) induced prostatitis model in rats. Intraprostatic capsaicin injection induced a pain reaction, including closing of the eyes, hypolocomotion, and tactile allodynia, which effects were ameliorated by LESW treatment. LESW therapy (2Hz, energy flux density of 0.12 mJ/mm2) at 200 and 300 shocks significantly decreased capsaicin-induced inflammatory reactions, reflected by a reduction of tissue edema and inflammatory cells, COX-2 and TNF-α stained positive cells, however, the therapeutic effects were not observed at 100 shocks treated group. Capsaicin-induced IL-1ß, COX-2, IL-6, caspase-1, and NGF upregulation on day 3 and 7, while NALP1 and TNF-α upregulation was observed on day 7. LESW significantly suppressed the expression of IL-1ß, COX-2, caspase-1, NGF on day 3 and IL-1ß, TNF-α, COX-2, NALP1, caspase-1, NGF expression on day 7 in a dose-dependent fashion. LESW has no significant effect on IL-6 expression. Intraprostatic capsaicin injection activates inflammatory molecules and induces prostatic pain and hypersensitivity, which effects were suppressed by LESW. These findings might be the potential mechanisms of LESW therapy for nonbacterial prostatitis in humans.


Asunto(s)
Capsaicina/efectos adversos , Mediadores de Inflamación/metabolismo , Dolor Pélvico/etiología , Dolor Pélvico/terapia , Prostatitis/etiología , Prostatitis/metabolismo , Terapia por Ultrasonido , Animales , Conducta Animal , Biomarcadores , Ciclooxigenasa 2/metabolismo , Citocinas/metabolismo , Modelos Animales de Enfermedad , Hipersensibilidad/etiología , Hipersensibilidad/terapia , Inmunohistoquímica , Masculino , Modelos Biológicos , Umbral del Dolor/efectos de la radiación , Prostatitis/complicaciones , Ratas , Factor de Necrosis Tumoral alfa/metabolismo , Terapia por Ultrasonido/métodos
8.
Molecules ; 24(12)2019 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-31216740

RESUMEN

The major objective of this study was to investigate the anti-chronic nonbacterial prostatitis (CNP) mechanism of T. patula by metabolomics and network pharmacology. The study demonstrated that the flavonoids and polysaccharides of T. patula could alleviate prostatitis by improving the level of DHT, reducing the secretion of PSA and TNF-α. Besides, both could enhance Na+/K+-ATPase activity, decrease the O2 consumption, CO2 production, heat production, energy expenditure of rats and promote respiratory exchange ratio of rats. Up to 28 potential biomarkers and 8 key metabolic pathways related to the treatment of CNP were elucidated by the metabolomics analysis, including phenylalanine metabolism, taurine and hypotaurine metabolism, tryptophan metabolism etc. Network pharmacology prediction also reflected the potential mechanism was associated with tryptophan metabolism and energy pathway. Generally, the potential anti-CNP mechanism of flavonoids and polysaccharides of T. patula might be through reducing the expression of inflammation factors, adjusting the level of hormone and regulating the amino acid metabolism, energy metabolism and glucose and lipid metabolism.


Asunto(s)
Biomarcadores , Metabolómica , Extractos Vegetales/farmacología , Prostatitis/tratamiento farmacológico , Prostatitis/metabolismo , Tagetes/química , Cromatografía Liquida , Enfermedad Crónica , Metabolismo Energético/efectos de los fármacos , Humanos , Masculino , Espectrometría de Masas , Redes y Vías Metabólicas/efectos de los fármacos , Metaboloma , Metabolómica/métodos , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Prostatitis/diagnóstico , Prostatitis/etiología
9.
Andrologia ; 51(5): e13245, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-30729553

RESUMEN

This study aimed to investigate the mechanism of Jiedu Huoxue decoction (JDHXD) in type III prostatitis based on the NF-κB signalling pathway. Twenty-six Sprague-Dawley male rats were divided into blank control, model, positive (Prostate Plus), low-dose JDHXD, medium-dose JDHXD and high-dose JDHXD groups. Type III prostatitis rat model was established and confirmed with HE staining. NF-кB P50 and NF-κB P65 expression was detected with immunohistochemistry. NF-κB mRNA expression was detected with qRT-PCR. Protein expression of NF-κB and its inhibitor Iκ-Bα was detected with Western blot. Compared to the model group, a decrease in glandular hyperplasia and inflammation, and in NF-кB P50 and NF-κB P65 expression in the medium- and high-dose JDHXD groups was observed. NF-κB mRNA expression was significantly increased in the model group compared to control (p < 0.05), and significantly decreased in the JDHXD treatment groups compared to model group (p < 0.05). Protein expression of NF-κB was significantly increased in the model and low-dose JDHXD groups compared to control(p < 0.05), and significantly decreased in the medium- and high-dose JDHXD groups compared to model group (p < 0.05). Protein expression of Iκ-Bα was vice versa. JDHXD could be a potential treatment for type III prostatitis via its regulation of NF-κB and Iκ-Bα expression.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Inhibidor NF-kappaB alfa/metabolismo , FN-kappa B/metabolismo , Prostatitis/tratamiento farmacológico , Transducción de Señal/efectos de los fármacos , Animales , Castración/efectos adversos , Enfermedad Crónica/tratamiento farmacológico , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/uso terapéutico , Estradiol/administración & dosificación , Estradiol/análogos & derivados , Estradiol/toxicidad , Humanos , Masculino , Prostatitis/etiología , Prostatitis/patología , Ratas , Ratas Sprague-Dawley
10.
Int Urol Nephrol ; 50(11): 1963-1973, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30141123

RESUMEN

PURPOSE: Folic acid (FA) intake has increased to high levels in many countries for the prevention of neural tube defects. However, the impact of excess FA intake, particularly before and during pregnancy, requires further investigation. Our aim was to investigate the effect of maternal folic acid supplementation on prostatitis risk in the rat offspring. METHODS: Female SD rats were administrated with different doses of FA by oral gavage from 2 weeks prior to mating to GD14: 0 mg/kg (distilled water), 0.2 mg/kg FA and 2.0 mg/kg FA respectively. The male rat offspring from each maternal FA group were castrated on PND56 and injected different doses of 17ß-estradiol (E2) subcutaneously for 30 days to induce prostatitis: 0 mg/kg (corn oil) and 1.25 mg/kg E2 respectively. At necropsy, the prostates were collected for histopathological analysis. Fasting blood was collected for the determination of serum E2, T, DHT, and folic acid levels. The expression of TNF-α, COX-2, and ER-α was determined by immunohistochemistry. RESULTS: High-dose (2.0 mg/kg) maternal folic acid supplementation significantly increased the proportion of prostatitis in FA(2.0) + E2(1.25) group (87.5%) compared with FA(0) + E2(1.25) group (25%). The inflammation was focal and severe, and large amounts of inflammatory cells appeared in different regions of the prostate in FA(2.0) + E2(1.25) group. The serum T, DHT, and FA levels in FA(2.0) + E2(1.25) group were significantly higher than those in FA(0) + E2(1.25) group. The expression of TNF-α, COX-2, and ER-α in three 1.25 mg/kg E2 groups presented positive, and the number and distribution of positive cells increased as FA dosage increased. CONCLUSIONS: Our findings suggest that high-dose (2.0 mg/kg) maternal folic acid supplementation significantly increases the proportion of prostatitis and the prostatic inflammation is more obvious and severe in the rat offspring.


Asunto(s)
Suplementos Dietéticos/efectos adversos , Ácido Fólico/efectos adversos , Fenómenos Fisiologicos de la Nutrición Prenatal , Prostatitis/etiología , Complejo Vitamínico B/efectos adversos , Animales , Femenino , Masculino , Embarazo , Prostatitis/patología , Ratas , Ratas Sprague-Dawley
11.
Urologe A ; 56(6): 759-763, 2017 Jun.
Artículo en Alemán | MEDLINE | ID: mdl-28455575

RESUMEN

Different strategies have been developed to reduce infectious complications following prostate biopsy. Various technical aspects like number of biopsies, needle size, route of biopsy, periprostatic nerve blockade, rectal preparation by enema, or disinfection with povidone-iodine have to be discussed. Regarding antibiotic therapy, choosing the optimal antibiotic, the duration of prophylaxis, combination therapy, and rectal swab-based antimicrobial therapy are of major interest. The current review gives answers to the different aspects.


Asunto(s)
Profilaxis Antibiótica/métodos , Biopsia/efectos adversos , Próstata/patología , Prostatitis/etiología , Prostatitis/prevención & control , Infecciones Urinarias/etiología , Infecciones Urinarias/prevención & control , Antibacterianos/administración & dosificación , Desinfección/métodos , Medicina Basada en la Evidencia , Alemania , Humanos , Masculino , Resultado del Tratamiento
12.
Urologe A ; 56(8): 1008-1016, 2017 Aug.
Artículo en Alemán | MEDLINE | ID: mdl-28401276

RESUMEN

Urogenital problems are dramatically increasing; especially chronic pelvic pain syndrome (CPPS) poses a major challenge for physicians and therapists. Few forms of therapy have been able to promise relief because the cause of CPPS remains unclear. Functional complaints are increasingly discussed as triggers. Osteopathic treatment has been reported to help many patients in recent years. In this article, the approach and osteopathic point of view of functional complaints are presented. In addition, possible causes for the development of CPPS and important anatomical structures that are directly involved in it are explained. Further interdisciplinary research of functional relationships would be desirable in the future.


Asunto(s)
Enfermedades Urogenitales Femeninas/diagnóstico , Enfermedades Urogenitales Femeninas/terapia , Enfermedades Urogenitales Masculinas/diagnóstico , Enfermedades Urogenitales Masculinas/terapia , Osteopatía , Dolor Pélvico/etiología , Dolor Pélvico/terapia , Enfermedad Crónica , Diagnóstico Diferencial , Femenino , Enfermedades Urogenitales Femeninas/etiología , Alemania , Humanos , Masculino , Enfermedades Urogenitales Masculinas/etiología , Prescripciones , Prostatitis/etiología , Prostatitis/terapia , Calidad de Vida , Síndrome , Resultado del Tratamiento
13.
Nat Prod Commun ; 12(1): 73-78, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30549829

RESUMEN

The present study investigated the effect of peanut sprout extract (PSE) as a natural resveratrol supplement on chronic bacterial prostatitis (CBP) and estradiol- induced benign prostatic hyperplasia (BPH). PSE contained a high level of resveratrol (148.51 ± 3.05 µg/g), and was tested on the mouse models of CBP . (induced by Escherichia coli 292 infection) and BPH (induced by treatment with ß-estradiol and dihydrotestosterdne). PSE toxicity was assessed on the basis of changes in body weight, alanine aminotransferase activity (an indicator of hepatotoxicity), and expression of the kidney injury marker KIM-1. The effects of PSE on the histopathology of prostate tissue, the proportion of neutrophils, and immune cell profiles in the blood and spleen were examined. PSE administration did not result in any toxicity but reduced the bacterial burden and histopathological changes in the prostate. In addition, lymphocytes (CD4⁺, CD8⁺, and CD 19⁺) in the spleen were significantly increased after PSE administration in CBP mice, suggesting immune enhancement. PSE treatment of bone Snarrow-derived macrophages increased the expression of CD40, which is related to the pro-inflammatory function and host defense against pathogens. It is concluded that PSE would be a good supplement for the mitigation of prostate hyperplasia and prostatitis.


Asunto(s)
Arachis/química , Infecciones Bacterianas/complicaciones , Infecciones Bacterianas/prevención & control , Extractos Vegetales/farmacología , Prostatitis/prevención & control , Resveratrol/farmacología , Lesión Renal Aguda , Animales , Infecciones por Escherichia coli/complicaciones , Infecciones por Escherichia coli/tratamiento farmacológico , Receptor Celular 1 del Virus de la Hepatitis A/metabolismo , Lipopolisacáridos , Linfocitos/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Extractos Vegetales/toxicidad , Hiperplasia Prostática/inducido químicamente , Hiperplasia Prostática/prevención & control , Prostatitis/inducido químicamente , Prostatitis/etiología
14.
Zhonghua Nan Ke Xue ; 23(3): 243-250, 2017 Mar.
Artículo en Chino | MEDLINE | ID: mdl-29706046

RESUMEN

OBJECTIVE: To investigate the effect of waist hot-compress with the Shirexiao (SRX) pad on the expressions of Th17/Treg-specific factors in the prostatic tissue of the mouse model of experimental autoimmune prostatitis (EAP) with damp heat syndrome, and explore its possible action mechanisms. METHODS: Twenty healthy male mice were included as normal controls and another 100 chosen for establishing the model of EAP with damp heat syndrome by subcutaneous injection of purified prostate protein solution from the Wistar rat and Freund's complete adjuvant using the TCM method. The model mice were randomly divided into five groups: model control, matrix, and low-, medium- and high-dose SRX. After chemical removal of the hair at lumbar vertebrae 1-3, the animals of the low-, medium- and high-dose SRX groups were treated with the SRX pad heated to 45℃ and externally applied to the non-hair area, qd, bid, and tid, respectively, 10 minutes each time, those of the matrix group with the vaseline pad, and those of the normal and model control groups with the saline pad. After 4 weeks of continuous treatment, all the mice were sacrificed for determination of the protein and mRNA expressions of RORγt and Foxp3 in the prostate tissue by Western blot and quantitative real-time PCR. RESULTS: The symptoms, signs and pathological changes of the EAP model mice were similar to the manifestations of chronic prostatitis. After intervention, the protein and mRNA expressions of Foxp3 were significantly down-regulated while those of RORγt markedly up-regulated in the EAP model group as compared with the normal control (P <0.05). In comparison with the model controls, the protein and mRNA expressions of RORγt were remarkably decreased in the medium- and high-dose SRX groups (P <0.05), that of the Foxp3 protein was markedly increased in the high-dose group (P <0.05), while that of Foxp3 mRNA exhibited no statistically significant difference in the low-, medium- or high-dose groups (P >0.05). CONCLUSIONS: The Shirexiao waist hot-compress therapy plays a positive role in the treatment of autoimmune prostatitis with damp heat syndrome by reducing the expression of RORγt, inhibiting the differentiation of Th17 and thus checking the differentiation imbalance of Th17/Treg.


Asunto(s)
Vendajes de Compresión , Calor , Miembro 3 del Grupo F de la Subfamilia 1 de Receptores Nucleares/metabolismo , Prostatitis/metabolismo , Linfocitos T Reguladores/metabolismo , Células Th17/metabolismo , Adyuvantes Inmunológicos , Animales , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos , Factores de Transcripción Forkhead/metabolismo , Adyuvante de Freund , Remoción del Cabello , Humanos , Masculino , Ratones , Prostatitis/etiología , ARN Mensajero/metabolismo , Distribución Aleatoria , Ratas , Ratas Wistar , Regulación hacia Arriba
15.
Int Urol Nephrol ; 48(11): 1763-1770, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27495324

RESUMEN

PURPOSE: The aim of this study was to evaluate the effect of povidone-iodine rectal disinfection and targeted antimicrobial prophylaxis in men undergoing transrectal ultrasound-guided prostate biopsy based on rectal swab culture results. METHODS: From January 2011 to December 2015, we studied differences in infectious complications in men who received povidone-iodine rectal disinfection with targeted antimicrobial prophylaxis and those who received empirical prophylaxis before transrectal ultrasound-guided prostate biopsy. Clinical variables including demographics, prior antibiotic, rectal swab culture results, povidone-iodine rectal cleansing, antibiotic prophylaxis, and infectious complications were evaluated. Patients were divided into three groups as follows: Group A received no povidone-iodine rectal cleansing but received empirical antimicrobial prophylaxis; group B received povidone-iodine rectal cleansing and empirical antimicrobial prophylaxis; and group C received povidone-iodine rectal cleansing and targeted antimicrobial prophylaxis. RESULTS: Patients were divided into group A (n = 192; 13.2 %), group B (n = 579; 39.9 %), or group C (n = 679; 46.8 %). In groups A and B, all patients received fluoroquinolone antimicrobial prophylaxis. Group C patients received targeted antimicrobial prophylaxis according to antibiotic resistance of rectal flora, and 71.1 % of these received fluoroquinolone antimicrobial prophylaxis. Infectious complication rates were 3.6, 2.9, and 1.3 % in group A, group B, and group C, respectively. Incidences of acute prostatitis and bacteremia were significantly lower in group C (p = 0.041 and p = 0.049, respectively) than in the other groups. CONCLUSIONS: In the era of quinolone resistance, the combination of povidone-iodine rectal cleansing and targeted antibiotic prophylaxis may reduce the rate of infectious complications.


Asunto(s)
Antibacterianos/uso terapéutico , Antiinfecciosos Locales/administración & dosificación , Profilaxis Antibiótica/métodos , Infecciones Bacterianas/prevención & control , Fluoroquinolonas/uso terapéutico , Povidona Yodada/administración & dosificación , Recto/microbiología , Anciano , Infecciones Bacterianas/etiología , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico/efectos adversos , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico/métodos , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/prevención & control , Próstata/patología , Prostatitis/etiología , Prostatitis/prevención & control
16.
Urologiia ; (3): 80-84, 2016 Aug.
Artículo en Ruso | MEDLINE | ID: mdl-28247635

RESUMEN

AIM: To improve treatment results of patients with CAP using hypercapnic hypoxia as a part of an integrated therapy. MATERIALS AND METHODS: The study involved 37 men aged 20 to 50 years diagnosed with CAP. The subjects were randomly divided into 2 groups. The control group consisted of 17 (46%) patients who received only the basic therapy. The study group comprised 20 (54%) patients, who were treated with the basic therapy combined with a course of 10 treatment sessions of hypercapnic hypoxia using a respiratory device. Two study visits were organized before and after treatment, including medical history, physical examination, filling out questionnaires, DRE and TRUS of the prostate, uroflowmetry and laser flowmetry. RESULTS: In the both groups, the treatment resulted in reduction or relief of pain and dysuria that is a natural effect of the standard therapy. However, the study group showed significantly greater improvement. The findings of DRE and TRUS of the prostate in the study and control group did not differ significantly; the size of hypoechoic areas in the prostate decreased in the both groups. Laser flowmetry showed improvement in microcirculatory disturbances of the prostate, which were observed before treatment. CONCLUSION: Basic therapy has a clinical effect, but it is limited regarding hemodynamics and microcirculation of the prostate. These indices are lower than in the study group. Thus, the study findings show a high clinical efficacy of hypercapnic hypoxia as an add-on therapy in treating patients with CAP. There was a significant decrease in clinical manifestations of the disease which was caused by improving microcirculation. This resulted from improved blood circulation, increased blood perfusion and blood volume in the arterioles, increased blood inflow in the microcirculatory system, reduced tissue hypoxia and ischemia, improved blood flow regulation. The findings of the present study give us ground to recommend training using breathing simulator "Karbonik" in the combination therapy of patients with CAP, which significantly increases the treatment effectiveness.


Asunto(s)
Hipercapnia , Hipoxia , Próstata , Prostatitis , Adulto , Humanos , Hipercapnia/complicaciones , Hipercapnia/fisiopatología , Hipoxia/complicaciones , Hipoxia/fisiopatología , Masculino , Persona de Mediana Edad , Próstata/irrigación sanguínea , Próstata/fisiopatología , Prostatitis/etiología , Prostatitis/fisiopatología
17.
Urol Int ; 96(2): 244-6, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-25138619

RESUMEN

Prostatic involvement in granulomatosis with polyangiitis (GWP), formerly known as Wegener's granulomatosis, is rare, mostly arising in the context of systemic involvement. Prostatic involvement as the first manifestation of this systemic disease is exceptionally rare. We hereby present the case of a 41-year-old male patient who underwent transurethral prostate resection for what was initially diagnosed as suppurative, focally necrotizing prostatitis. Prolonged postoperative fever that did not respond to various treatments, as well as the subsequent appearance of a left pleural effusion, a left upper pulmonary lobe lesion and cutaneous nodules, led to a reevaluation of histological slides which, along with the determination of serum c-ANCA/anti-PR3 antibody levels, established the diagnosis of GWP. Physicians, and especially urologists and infectious diseases specialists, should be aware of this rare association and consider GWP in the event of nonresolving prostatitis, especially when characteristic symptoms from other systems appear.


Asunto(s)
Absceso/diagnóstico , Granulomatosis con Poliangitis/diagnóstico , Prostatitis/diagnóstico , Adulto , Antibacterianos/uso terapéutico , Biopsia , Errores Diagnósticos , Granulomatosis con Poliangitis/complicaciones , Granulomatosis con Poliangitis/terapia , Humanos , Inmunosupresores/uso terapéutico , Masculino , Valor Predictivo de las Pruebas , Prostatitis/etiología , Prostatitis/terapia , Supuración , Resección Transuretral de la Próstata , Resultado del Tratamiento
18.
Korean J Urol ; 55(11): 732-6, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25405015

RESUMEN

PURPOSE: Transrectal ultrasound (TRUS)-guided biopsy of the prostate is usually safe. However, some patients are hospitalized owing to complications from TRUS biopsy. We identified the risk factors for complications and effective preventive measures for treating complications after TRUS biopsy. MATERIALS AND METHODS: Medical records and radiological images of 1,083 patients who underwent TRUS biopsy of the prostate over 10 years in Gyeongsang National University Hospital were examined retrospectively to investigate the correlation between complications after TRUS biopsy and preventive antibiotics, prebiopsy enema, number of biopsy cores, and pathological findings. RESULTS: Complications occurred in 69 patients (6.4%). The complication rates of the 1,008 patients who received antibiotics and the 75 patients who did not were 6.3% and 8.0%, respectively (p=0.469). Complication rates of the pre-biopsy enema group (n=658) and the group without prebiopsy enema (n=425) were 4.7% and 8.9%, respectively (p=0.007). Complication rates of the 6-core biopsy group (n=41) and the 12-core biopsy group (n=955) were 7.3% and 6.3%, respectively (p=0.891). Complication rates of the prostate cancer group (n=306) and the no prostate cancer group (n=713) were 6.2% and 6.6%, respectively (p=0.740). CONCLUSIONS: A prebiopsy enema was associated with a reduced risk of complications after TRUS biopsy. Preventive antibiotics, number of biopsy cores, and pathological findings did not significantly influence the complication rate.


Asunto(s)
Endosonografía , Enema/métodos , Biopsia Guiada por Imagen/efectos adversos , Neoplasias de la Próstata/patología , Prostatitis/prevención & control , Síncope Vasovagal/prevención & control , Retención Urinaria/prevención & control , Anciano , Humanos , Biopsia Guiada por Imagen/métodos , Incidencia , Masculino , Prostatitis/epidemiología , Prostatitis/etiología , Recto , República de Corea/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Síncope Vasovagal/epidemiología , Síncope Vasovagal/etiología , Retención Urinaria/epidemiología , Retención Urinaria/etiología
20.
Zhonghua Nan Ke Xue ; 19(5): 451-5, 2013 May.
Artículo en Chino | MEDLINE | ID: mdl-23757971

RESUMEN

OBJECTIVE: To observe the changes of inflammatory cytokines in autoimmune prostatitis (AIP) rats treated by electro-acupuncture (EA) at Sanyin points. METHODS: We selected 40 Wistar male rats in this study, 10 as normal controls, and the other 30 made AIP models by intradermal injection of protein purification liquid from the prostate of allogeneic male rats with dual immune adjuvant. Then we randomly divided the AIP models into a model, a Cernilton control and an EA group of equal number, the latter two groups treated by Cernilton enema and EA, respectively. After 15 days of treatment, all the animals were sacrificed for detection of the levels of TNF-alpha, iNOS, MDA and T-AOC in the prostate tissue. RESULTS: Compared with the normal controls, the model rats showed significantly elevated TNF-alpha expression ([15.31 +/- 1.36] vs [32.20 +/- 1.65] pg/ml, P < 0.01), iNOS activity ([0.81 +/- 0.33] vs [1.25 +/- 0.23] U/ml, P < 0.01) and MDA content ([0.66 +/- 0.14] vs [0.91 +/- 0.21] nmol/ml, P < 0.05), but markedly reduced T-AOC activity ([1.56 +/- 0.16] vs [1.11 +/- 0.15] U/ml, P < 0.01). In comparison with the model group, the EA group exhibited significantly reduced levels of TNF-alpha ([17.32 +/- 2.69 ] pg/ml, P < 0.01), iNOS ([0.98 +/- 0.5 ] U/ml, P < 0.05) and MDA ([0.70 +/- 0.20] nmol/ml, P < 0.05), but remarkably increased level of T-AOC ([1.44 +/- 0.26] U/ml, P < 0.05). CONCLUSION: Electro-acupuncture at Sanyin points can protect the prostate tissue from morphological damage and reduce inflammatory reaction by decreasing pro-inflammatory cytokine activity, vascular permeability and inflammatory cell infiltration and increasing the activity of the antioxidant defense system.


Asunto(s)
Puntos de Acupuntura , Electroacupuntura , Prostatitis/metabolismo , Prostatitis/terapia , Animales , Citocinas/metabolismo , Modelos Animales de Enfermedad , Inflamación , Masculino , Malondialdehído/metabolismo , Óxido Nítrico Sintasa/metabolismo , Próstata/metabolismo , Prostatitis/etiología , Ratas , Ratas Wistar , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA